AUSTIN, Texas–(BUSINESS WIRE)– Asuragen, Inc., a molecular diagnostics company changing the way diagnostics impact patient care in genetics and oncology, announced today the availability of
300 Montgomery Street
Suite 1130
San Francisco, CA 94104